Cargando…
Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, so there is an urgent need to suppress its development at early stage. Shenkang pills (SKP) are a hospital prescription selected and optimized from effective traditional Chinese medicinal formulas for clinical treatment of DN...
Autores principales: | Wang, Fujing, Fan, Jia’er, Pei, Tingting, He, Zhuo’en, Zhang, Jiaxing, Ju, Liliang, Han, Zhongxiao, Wang, Mingqing, Xiao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873791/ https://www.ncbi.nlm.nih.gov/pubmed/35222021 http://dx.doi.org/10.3389/fphar.2022.781806 |
Ejemplares similares
-
Turning RacGAP into a RhoGAP
por: Tuma, Rabiya S.
Publicado: (2003) -
RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1–IQGAP1 complex
por: Jacquemet, Guillaume, et al.
Publicado: (2013) -
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling
por: Chen, Hualin, et al.
Publicado: (2023) -
MgcRacGAP restricts active RhoA at the cytokinetic furrow and both RhoA and Rac1 at cell–cell junctions in epithelial cells
por: Breznau, Elaina B., et al.
Publicado: (2015) -
The RacGAP β-Chimaerin is essential for cerebellar granule cell migration
por: Estep, Jason A., et al.
Publicado: (2018)